241 results
Robert Steinglass, Frances Mwansa, Guissimon Phiri, Wendy Prosser, Natasha Kanagat, Ali Karim, Barbara Knittel, Kirstin Krudwig
Abstract Introduction Vaccines procured for low-income countries are often packaged in multi-dose vials to reduce program costs. To avoid wastage, health workers may refrain from opening a vial if...
Linksbridge
Collection of resources for switch to 5-dose MCV vials.
International Vaccine Access Center (IVAC), Johns Hopkins University
VIEW-hub is an open-access data visualization tool that displays data on vaccine introduction, use, coverage, access, impact, and disease burden for nine vaccines, including measles-containing...
International Vaccine Access Center (IVAC), Johns Hopkins University
VIEW-hub is an open-access data visualization tool that displays data on vaccine introduction, use, coverage, access, impact, and disease burden for nine vaccines, including measles-containing...
UNICEF
The document provides an overview of prices per vaccine contracted by UNICEF with suppliers.
UNICEF
This table provide an overview of prices contracted with suppliers by UNICEF per vaccine.
UNICEF
This table provide an overview of prices contracted with suppliers by UNICEF per vaccine.
UNICEF
Nationally representative household survey that provides data for wide range of monitoring and impact evaluation indicators in the areas of population, health and nutrition.
Andrew Pollard, Kristen Earle
Narendra Arora, INCLEN; Naor Bar-Zeev, WHO; Rudzani Muloiwa, U. Cape Town; Deborah Watson-Jones, LSHTM
International Vaccine Access Center (IVAC)
VIEW-hub is an easy to use repository for the most relevant and recent vaccine data, covering topics such as Vaccine Introduction & Use, Immunization Equity, Vaccine Preventable Disease Burden, and...
World Health Organization (WHO)
Mick N. Mulders
Annex 17 Generating Consensus Sequences with Sequencher
Mick N. Mulders
Annex C 16: CDC Protocol for amplification and sequencing of measles virus MF-NCR from patient samples
World Health Organization (WHO)
The conclusions of the Global Measles and Rubella Strategic Plan 2012–2020 implementation midterm review highlighted the need to update protocols for guiding surveillance and outbreak investigation...
Rebecca Fields
Rudi Eggers (WHO), Jan Grevendonk (WHO), Elicah Kandinda Kamiji (MoH Zambia), Imran Mirza (UNICEF), Abigail Shefer (US CDC)
A. A. Adeyemo
Narendra Arora (INCLEN), Peter Figueroa (U of the West Indies), Jim Goodson (US CDC), Shabir Madhi (NICD, South Africa), Peter Strebel (WHO), Kim Thompson (Kids Risk)
World Health Organization (WHO)
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each...
Edson Utazi, Dan Hogan
Communities at risk of non- and under-vaccination are often characterized by poverty, lack of access to health care and other basic services, civil/political unrest, poor sanitation practices,...
Vaccine Impact Modelling Consortium
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a...
Mateusz Hasso-Agopsowicz
Les vaccins contre la rougeole et la rubéole sont sûrs et efficaces, mais la couverture équitable, en particulier pour la deuxième dose de vaccin contenant la rougeole (MCV2), est bien...
Kirstin Krudwig, Wendy Prosser
Le COVID exigeant des sessions de plus petite taille, il est plus important que jamais de réduire la taille des flacons de vaccins pour mieux les adapter à la taille des sessions. Cette...
Mateusz Hasso-Agopsowicz
Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second dose of measles containing vaccine (MCV2) is well below the 95% target of...
WHO - Regional office for South-East Asia
The specific objectives of the review were to: i) provide a candid estimation or review of the progress towards achieving the regional goal by 2023; ii) assess the quality of implementation...
Mick N. Mulders
Annex C15. Using the RECall program
Mick N. Mulders
Comparison of measles and rubella IgM EIA kits
Mick N. Mulders
Dried blood spot (DBS) protocols
Mick N. Mulders
Invitrogen Real Time PCR Template: Rubella
Mick N. Mulders
Invitrogen Real Time PCR Template
Mick N. Mulders
Invitrogen Real Time PCR Template: Rubella with Diluted ROX
Mick N. Mulders
Real-time RT-PCR Assays for the Detection of Measles Virus (MeV) N Gene RNA and Human RNase P mRNA (a cellular reference gene) using the ABI 7500 Real-Time Thermocycler
Mick N. Mulders
Real-time RT-PCR Assays for the Detection of Rubella Virus RNA and Human RNase P mRNA using the ABI 7500 Real-time Thermocycler
Mick N. Mulders
RT-PCR protocol for rubella genotyping using nested set amplifications Enzyme kit: Qiagen One-Step RT-PCR
Mick N. Mulders
Verification for new IgM EIAs
Mick N. Mulders
Measles or rubella virus isolation and preparation of virus stocks